ItherX Pharmaceuticals, Inc. Appoints Stefan Zeuzem, M.D., as Chair of Scientific and Clinical Advisory Board
3/15/2011 7:29:28 AM
More...
|
ItherX Pharmaceuticals, Inc. Initiates Phase 1b Study of First-in-Class Hepatitis C Virus Entry Inhibitor ITX-5061
3/15/2011 7:28:41 AM
More...
|
ItherX Pharmaceuticals, Inc. to Initiate Proof of Concept Clinical Study for First-in-Class Treatment for Hepatitis C
2/3/2009 9:46:56 AM
More...
|
ItherX Pharmaceuticals, Inc. Appoints Scientific and Clinical Advisory Board for Hepatitis C Antiviral Drugs
8/19/2008 8:33:37 AM
More...
|
Immusol, Inc. Changes Name to ItherX, Names New CEO
12/17/2007 7:19:25 AM
More...
|